Histopathology of lung adenocarcinoma based on new IASLC/ATS/ERS classification: Prognostic stratification with functional and metabolic imaging biomarkers

Journal of Magnetic Resonance Imaging

Volumn 38, Issue 4, 2013, Pages 905-913

  Lee, Ho Yun ^a   Jeong, Ji Yun ^a   Lee, Kyung Soo ^a   Yi, Chin A ^a   Kim, Byung Tae ^a   Kang, Hee ^a   Kwon, O Jung ^a   Shim, Young Mog ^a   Han, Joungho ^a,b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

diffusion weighted MR imaging (DWI); histology; lung adenocarcinoma; positron emission tomography (PET); prognosis

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG ADENOCARCINOMA; MALE; PET SCANNER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

DIFFUSION-WEIGHTED MR IMAGING (DWI); HISTOLOGY; LUNG ADENOCARCINOMA; POSITRON EMISSION TOMOGRAPHY (PET); PROGNOSIS;

ADENOCARCINOMA; ADULT; AGED; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 84886873240     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24080     Document Type: Article

References (31)

1. Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007; 2: 706-714.
2. Lee HY, Jeong JY, Lee KS, et al. Solitary pulmonary nodular lung adenocarcinoma: correlation of histopathologic scoring and patient survival with imaging biomarkers. Radiology 2012; 264: 884-893.
3. Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011; 6: 244-285.
4. Sica G, Yoshizawa A, Sima CS, et al. A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors. Am J Surg Pathol 2010; 34: 1155-1162.
5. Yoshizawa A, Motoi N, Riely GJ, et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol 2011; 24: 653-664.
6. Warth A, Muley T, Meister M, et al. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J Clin Oncol 2012; 30: 1438-1446.
7. Russell PA, Wainer Z, Wright GM, Daniels M, Conron M, Williams RA,. Does lung adenocarcinoma subtype predict patient survival?: a clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification. J Thorac Oncol 2011; 6: 1496-1504.
8. Hsu PP, Sabatini DM,. Cancer cell metabolism: Warburg and beyond. Cell 2008; 134: 703-707.
9. Matoba M, Tonami H, Kondou T, et al. Lung carcinoma: diffusion-weighted mr imaging-preliminary evaluation with apparent diffusion coefficient. Radiology 2007; 243: 570-577.
10. Satoh S, Kitazume Y, Ohdama S, Kimula Y, Taura S, Endo Y,. Can malignant and benign pulmonary nodules be differentiated with diffusion-weighted MRI? AJR Am J Roentgenol 2008; 191: 464-470.
11. Lee HY, Han J, Lee KS, et al. Lung adenocarcinoma as a solitary pulmonary nodule: prognostic determinants of CT, PET, and histopathologic findings. Lung Cancer 2009; 66: 379-385.
12. Paesmans M, Berghmans T, Dusart M, et al. Primary tumor standardized uptake value measured on fluorodeoxyglucose positron emission tomography is of prognostic value for survival in non-small cell lung cancer: update of a systematic review and meta-analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project. J Thorac Oncol 2010; 5: 612-619.
13. Koyama H, Ohno Y, Aoyama N, et al. Comparison of STIR turbo SE imaging and diffusion-weighted imaging of the lung: capability for detection and subtype classification of pulmonary adenocarcinomas. Eur Radiol 2010; 20: 790-800.
14. Goldstraw P, editor. International Association for the Study of Lung Cancer Staging Manual in Thoracic Oncology, 1st ed. Orange Park, FL: Editorial Rx Press; 2009.
15. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti AI, editors. AJCC cancer staging manual, 7th ed. New York, NY: Springer; 2009.
16. Shim SS, Lee KS, Kim BT, et al. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology 2005; 236: 1011-1019.
17. Padhani AR, Liu G, Koh DM, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009; 11: 102-125.
18. Lester SC, editor. Manual of surgical pathology, 2nd ed. New York, NY: Elsevier Churchill Livingstone; 2006.
19. Kadota K, Colovos C, Suzuki K, et al. FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma. Ann Surg Oncol 2012; 19: 3598-3605.
20. Ng SH, Yen TC, Chang JT, et al. Prospective study of [18F] fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. J Clin Oncol 2006; 24: 4371-4376.
21. Chung MK, Jeong HS, Park SG, et al. Metabolic tumor volume of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer. Clin Cancer Res 2009; 15: 5861-5868.
22. Herneth AM, Guccione S, Bednarski M,. Apparent diffusion coefficient: a quantitative parameter for in vivo tumor characterization. Eur J Radiol 2003; 45: 208-213.
23. Chung CK, Zaino R, Stryker JA, O'Neill M Jr, DeMuth WE Jr,. Carcinoma of the lung: evaluation of histological grade and factors influencing prognosis. Ann Thorac Surg 1982; 33: 599-604.
24. Barletta JA, Yeap BY, Chirieac LR,. Prognostic significance of grading in lung adenocarcinoma. Cancer 2010; 116: 659-669.
25. Amin MB, Tamboli P, Merchant SH, et al. Micropapillary component in lung adenocarcinoma: a distinctive histologic feature with possible prognostic significance. Am J Surg Pathol 2002; 26: 358-364.
26. Miyoshi T, Satoh Y, Okumura S, et al. Early-stage lung adenocarcinomas with a micropapillary pattern, a distinct pathologic marker for a significantly poor prognosis. Am J Surg Pathol 2003; 27: 101-109.
27. Prior JO, Stupp R, Christodoulou M, Letovanec I,. Micropapillary pattern in lung adenocarcinoma: aspect on 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging. Interact Cardiovasc Thorac Surg 2010; 10: 144-145.
28. Sun JS, Park KJ, Sheen SS, et al. Clinical usefulness of the fluorodeoxyglucose (FDG)-PET maximal standardized uptake value (SUV) in combination with CT features for the differentiation of adenocarcinoma with a bronchioloalveolar carcinoma from other subtypes of non-small cell lung cancers. Lung Cancer 2009; 66: 205-210.
29. Chiu CH, Yeh YC, Lin KH, et al. Histological subtypes of lung adenocarcinoma have differential 18F-fluorodeoxyglucose uptakes on the positron emission tomography/computed tomography scan. J Thorac Oncol 2011; 6: 1697-1703.
30. Liu H, Liu Y, Yu T, Ye N,. Usefulness of diffusion-weighted MR imaging in the evaluation of pulmonary lesions. Eur Radiol 2010; 20: 807-815.
31. Yankeelov TE, Peterson TE, Abramson RG, et al. Simultaneous PET-MRI in oncology: a solution looking for a problem? Magn Reson Imaging 2012; 30: 1342-1356.